Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Therapy for aplastic anemia

    ... registry, including cord blood. He is red cell- and platelet transfusion -dependent. He has been recommended therapy with ...

    Research Article last updated 01/09/2012 - 10:58am.

  2. The long term risk of myelodysplastic syndromes among anemia patients: A population-based study.

    ... white blood cell count of less than 3500/mm(3), and platelet count of less than 100×10(9)/L were associated with a ...

    Research Article last updated 12/12/2011 - 9:55am.

  3. Epidemiology and risk factors for infections in myelodysplastic syndromes.

    ... (HR 2.9, 95% CI = 1.4-6.0, P < 0.005). Age, nadir platelet count <20,000/mL, diabetes mellitus, and MDS treatment were not ...

    Research Article last updated 09/17/2013 - 2:12pm.

  4. Loss of expression of neutrophil proteinase-3: a contributory factor in thrombotic risk in paroxysmal nocturnal hemoglobinuria.

    ... Finally, we studied the effects of proteinase 3 on platelet activation using an in vitro aggregometry assay and flow ...

    Research Article last updated 10/11/2011 - 5:58pm.

  5. Comparison between Matched Related and Alternative Donors of Allogeneic Hematopoietic Stem Cells Transplanted into Adult Patients with Acquired Aplastic Anemia: Multivariate and Propensity Score-Matched Analysis.

    ... absence of acute graft-versus-host disease (aGVHD), and platelet engraftment at ≤21 days, were independent predictors of longer ...

    Research Article last updated 10/11/2011 - 5:58pm.

  6. Comparison of Outcomes after Transplantation of G-CSF-Stimulated Bone Marrow Grafts versus Bone Marrow or Peripheral Blood Grafts from HLA-Matched Sibling Donors for Patients with Severe Aplastic Anemia.

    ... in 1997 to 2003. Rates of neutrophil and platelet recovery were not different among the 3 treatment groups. Grade ...

    Research Article last updated 10/11/2011 - 5:58pm.

  7. Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: A report on 62 cases.

    ... del 20q and patients without del 20q were lower platelet count (mean 144 vs. 196 G/l, p=0.005), lower marrow blast count ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. Eltrombopag restores tri-lineage hematopoiesis in refractory severe aplastic anemia which can be sustained on discontinuation of drug

    ... increases in neutrophil , red cell and platelet lineages. Five patients with robust near-normalization of blood ...

    Research Article last updated 01/07/2014 - 12:22pm.

  9. Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia-a single-center experience.

    ... rapid engraftment; mean time for neutrophil and platelet recovery was 13.95 d and 20.27 d, respectively. No acute toxicity ...

    Research Article last updated 07/09/2013 - 2:48pm.

  10. Eltrombopag and improved hematopoiesis in refractory aplastic anemia

    ... minimal toxic effects. Nine patients no longer needed platelet transfusions (median increase in platelet count, 44,000 per cubic millimeter). Six patients had improved ...

    Research Article last updated 07/31/2012 - 2:24pm.